Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sciformix Executives Drive Agenda on Achieving Drug Safety Excellence at World Drug Safety Congress

Published: Thursday, March 28, 2013
Last Updated: Thursday, March 28, 2013
Bookmark and Share
5th Annual World Drug Safety Congress to be held from April 24 - 25, 2013 at Boston, USA.

Sciformix Corporation has announced its premium sponsorship of the 5th annual World Drug Safety Congress, taking place from April 24 - 25, 2013 at the Revere Hotel Boston Common, Boston, USA.

The World Drug Safety Congress addresses strategic and crucial issues in the development and execution of drug safety programs.

Senior executives of Sciformix, will be chairing the opening session and setting the stage on how organizations can stay on top of international regulatory requirements and streamline their drug safety programs.

Sciformix, premium sponsors of the event for the third year in a row, continues its success in its global delivery of services and solutions in Safety and Risk Management.

Their scientific and safety experts work closely with the top global pharmaceutical and biopharmaceutical, generics, consumer product and medical devices organizations to support their safety needs throughout the entire product lifecycle.

With substantial growth in business year on year, Sciformix is taking its position as a leader in drug safety services.

The World Drug Safety Congress aims to present innovative solutions to the key safety challenges facing both pharmaceutical industry and pharmacovigilance professionals worldwide.

It brings together senior personnel from a range of global pharmaceutical companies, regulatory agencies and academic institutions to share their expertise in the drug safety arena.

The conference provides an excellent opportunity for attendees to discuss diverse issues related to drug safety with specialists and practitioners.

At the conference, Sciformix will be demonstrating its expertise by engaging with the speakers and delegates, sharing their knowledge of key developments in the global drug safety market, and demonstrating solutions that provide competitive advantage to participating companies.

Manish Soman, President and CEO comments “We are delighted to be a part of the World Drug Safety Congress. Our support of the event is part of our ongoing investment in the field of drug safety. We want to share the knowledge we have gained while working with clients over the years, which has been incorporated into our innovative methodology and approaches to the problems of drug safety and risk management”.

To help drug safety professionals achieve excellence, world renowned expert Sidney Kahn, Senior Principal Pharmacovigilance Practice at Sciformix, will be addressing the audience with his keynote presentation on “The challenges in achieving excellence in the rapidly evolving global drug safety environment”.

On the second day of the conference, Chitra Lele, Chief Scientific Officer and co-founder at Sciformix will host an in-depth presentation and panellist discussion on “Taking the noise out of signal detection”.

Experts including Ram Tiwari, Ph.D., Associate Director, Office of Biostatistics, Center for Drug Evaluation & Research, US FDA and Michael Sprafka, Executive Director of Observation Research, Head of Pharmacovigilance-Epidemiology, Amgen, will provide practical solutions to the problems of inadequacies of available quantitative measures and indicate possible enhancements of the method during an informative and thought provoking presentation and panel discussion.

Sciformix partners with their clients through the entire drug development cycle, to provide a full range of services from study design to post marketing surveillance and commercialization support.

Areas of specialization include Safety and Risk Management, Clinical Research & Post Approval Services, Medical Affairs, Scientific Writing and Regulatory Affairs.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!